UBS Group AG
- SEC CIK
- 0001610520
- Latest filing
- Aug 13, 2026
OMIC holding history
Singular Genomics Systems, Inc. in every 13F filed by UBS Group AG, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
OMIC overviewAll 13F holders of OMICFull Q2 2026 holdings
- Shares (Q1 2025)
- 0
- Sold out in Q1 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 14
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2025 | 0 | $0 | 0.0% | −156,254−100.0% | Sold out | Holders |
| Q4 2024 | 156,254 | $3.04M | <0.1% | +78,270+100.4% | Added | Holders |
| Q3 2024 | 77,984 | $1.22M | <0.1% | +77,984 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −73,646−100.0% | Sold outConverted for a 1-for-30 split | Holders |
| Q1 2024 | 2,209,383 | $1.14M | <0.1% | +330.0% | Added | Holders |
| Q4 2023 | 2,209,350 | $1.02M | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 2,209,350 | $841.8K | <0.1% | −2,470,311−52.8% | Reduced | Holders |
| Q2 2023 | 4,679,661 | $3.88M | <0.1% | −18,108−0.4% | Reduced | Holders |
| Q1 2023 | 4,697,769 | $5.68M | <0.1% | −2,701−0.1% | Reduced | Holders |
| Q4 2022 | 4,700,470 | $9.45M | <0.1% | +25,025+0.5% | Added | Holders |
| Q3 2022 | 4,675,445 | $11.7M | <0.1% | +143,465+3.2% | Added | Holders |
| Q2 2022 | 4,531,980 | $17.3M | <0.1% | −33,740−0.7% | Reduced | Holders |
| Q1 2022 | 4,565,720 | $28.8M | <0.1% | +4,454,819+4,016.9% | Added | Holders |
| Q4 2021 | 110,901 | $1.28M | <0.1% | +90,051+431.9% | Added | Holders |
| Q3 2021 | 20,850 | $233.0K | <0.1% | +20,750+20,750.0% | Added | Holders |
| Q2 2021 | 100 | $3.00K | <0.1% | +100 | New | Holders |